Showing results (411-420 of 603) with videos related to

Sort By:
Pageof 61
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 9, 2024
ASMase is Essential for the Immune Response to Partial-Tumor Radiation ExposureMickael Mathieu, Prerna R Nepali, James Russell, et al.
International Journal of Surgery (London, England)|August 2, 2020
Bullying and undermining behaviours in surgery: A qualitative study of surgical trainee experiences in the United Kingdom (UK) & Republic of Ireland (ROI)Joshua Michael Clements, Martin King, Rebecca Nicholas, et al.
Nuclear Medicine and Biology|March 27, 2014
PET quantification with a histogram derived total activity metric: superior quantitative consistency compared to total lesion glycolysis with absolute or relative SUV thresholds in phantoms and lung cancer patientsIrene A Burger, Hebert Alberto Vargas, Aditya Apte, et al.
Physics in Medicine and Biology|October 7, 2010
Using an external gating signal to estimate noise in PET with an emphasis on tracer avid tumorsC R Schmidtlein, B J Beattie, D L Bailey, et al.
Microbiology Spectrum|October 20, 2021
Comparative Analysis of the Cultured and Total Bacterial Community in the Wheat Rhizosphere Microbiome Using Culture-Dependent and Culture-Independent ApproachesSameh H Youseif, Fayrouz H Abd El-Megeed, Ethan A Humm, et al.
Annals of Surgical Innovation and Research|February 24, 2009
Portable PET probes are a novel tool for intraoperative localization of tumor depositsVivian E Strong, Charles J Galanis, Christopher C Riedl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2009
Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiographyXiao-Feng Li, Xiaorong Sun, Yuanyuan Ma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2001
Relative therapeutic efficacy of (125)I- and (131)I-labeled monoclonal antibody A33 in a human colon cancer xenograftE C Barendswaard, J L Humm, J A O'Donoghue, et al.
British Journal of Cancer|February 1, 1990
Preliminary observations on the microdistribution of labelled antibodies in human colonic adenocarcinoma xenografts: relevance to microdosimetryR B Pedley, G M Boxer, J A Boden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2019
Pharmacokinetic Assessment of <sup>18</sup>F-(2<i>S,</i>4<i>R</i>)-4-Fluoroglutamine in Patients with CancerMilan Grkovski, Reema Goel, Simone Krebs, et al.
Pageof 61